Skip to main content
Premium Trial:

Request an Annual Quote

Compugen, DiagnoCure Win $800K Grant to Develop Lung-Cancer Diagnostic

NEW YORK, March 13 - Compugen and biotech company DiagnoCure have won an $800,000 grant from the Canada-Israel Industrial Research and Development Foundation to create a nucleic-acid probe-based diagnostic for lung cancer.

 

DiagnoCure, based in Quebec City, and Compugen, of Tel Aviv, announced in January their plans to co-develop and commercialize molecular-diagnostic tests that may help researchers detect certain epithelial cancers, such as lung cancer.

 

Terms of that agreement call for Compugen to identify and validate disease markers. DiagnoCure, meanwhile, brings to the table its experience in developing, manufacturing, and commercializing molecular-diagnostic assays.

 

Financial details of the deal were not disclosed.

 

The CIIRDF was established to "promote collaborative R&D between companies in Canada and Israel, by providing information to firms in both countries on R&D partnering potential, and by supporting national industrial R&D initiatives through its funding contribution," the group said in a statement.

 

"The DiagnoCure-Compugen lung cancer project is exactly the kind of high potential initiative that we look to support," Henri Rothschild, president of the CIIRDF, said in the statement.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.